These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16478692)

  • 21. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
    Ranjeva JP; Audoin B; Pelletier J; Confavreux C
    Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
    Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
    Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F; Rovaris M; Pagani E; Sormani MP; Comi G; Filippi M
    Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
    Zivadinov R
    Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.
    Nessler S; Boretius S; Stadelmann C; Bittner A; Merkler D; Hartung HP; Michaelis T; Brück W; Frahm J; Sommer N; Hemmer B
    Brain; 2007 Aug; 130(Pt 8):2186-98. PubMed ID: 17617655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
    Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
    Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated cranial nerve palsies in multiple sclerosis.
    Zadro I; Barun B; Habek M; Brinar VV
    Clin Neurol Neurosurg; 2008 Nov; 110(9):886-8. PubMed ID: 18374477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy for multiple sclerosis.
    Weiner HL; Hohol MJ; Khoury SJ; Dawson DM; Hafler DA
    Neurol Clin; 1995 Feb; 13(1):173-96. PubMed ID: 7739502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Functional magnetic resonance imaging in multiple sclerosis].
    Korsholm K; Mathiesen HK; Lund TE
    Ugeskr Laeger; 2007 Jun; 169(26):2518-20. PubMed ID: 17725897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Picturing multiple sclerosis: conventional and diffusion tensor imaging.
    Fox RJ
    Semin Neurol; 2008 Sep; 28(4):453-66. PubMed ID: 18843574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis.
    Courtney AM; Treadaway K; Remington G; Frohman E
    Med Clin North Am; 2009 Mar; 93(2):451-76, ix-x. PubMed ID: 19272518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
    Arnett HA; Viney JL
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R; Sepcić J
    Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
    Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A
    Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current developments in the area of multiple sclerosis].
    Polman CH; Koetsier JC
    Ned Tijdschr Geneeskd; 1994 Jan; 138(1):10-6. PubMed ID: 8289951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.